News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Opexa Therapeutics (OPXA) Recognizes World MS Day and Will Present Poster With Secondary Progressive Multiple Sclerosis Data at CMSC / ACTRIMS Annual Meeting



5/29/2013 7:44:19 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing a patient specific T-cell immunotherapy for multiple sclerosis (MS), today honored World MS Day with a renewed commitment to the multiple sclerosis community. Opexa will be sponsoring a booth and will be presenting baseline data from its Immune Monitoring Program in a poster session at the 2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) & the Fifth Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) May 29 – June 1 in Orlando, Florida.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES